NCT01552226

Brief Summary

This is a prospective randomized study of 114 patients. The purpose of this study is to compare the efficacy of two standard methods of analgesia for pain control in patients undergoing elective colon and rectal surgery, as measured by the Numeric Pain Scale (NPS) and by the need for supplemental narcotic analgesics. This study is designed to determine if postoperative pain control by local analgesics delivered through preperitoneally placed ON-Q Silver Soakerâ„¢ catheters (CPA) is equivalent to continuous epidural analgesia (CEA).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

February 28, 2012

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 13, 2012

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
10.6 years until next milestone

Results Posted

Study results publicly available

September 15, 2025

Completed
Last Updated

September 15, 2025

Status Verified

August 1, 2025

Enrollment Period

5.2 years

First QC Date

February 28, 2012

Results QC Date

January 9, 2025

Last Update Submit

August 26, 2025

Conditions

Outcome Measures

Primary Outcomes (6)

  • Postoperative Numerical Pain Score-Day 0

    Measured by the patient using the numerical pain scale (NPS). NPS is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable".

    Post-operative day 0

  • Postoperative Numerical Pain Score-Day 1

    Measured by the patient using the numerical pain scale (NPS). NPS is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable".

    Post-operative day 1

  • Postoperative Numerical Pain Score-Day 2

    Measured by the patient using the numerical pain scale (NPS). NPS is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable".

    Post-operative day 2

  • Postoperative Numerical Pain Score-Day 3

    Measured by the patient using the numerical pain scale (NPS). NPS is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable".

    Post-operative day 3

  • Postoperative Numerical Pain Score-Day 4

    Measured by the patient using the numerical pain scale (NPS). NPS is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable".

    Post-operative day 4

  • Postoperative Numerical Pain Score (NPS)- Post-Anaesthesia Care Unit (PACU)

    Postoperative NPS is a pain screening tool, commonly used to assess the pain severity a patient experiences after surgery, where "0" indicates no pain and "10" represents the worst pain imaginable".

    After surgery in the post-anesthesia care unit

Secondary Outcomes (5)

  • Patient Use of Supplemental Narcotic Analgesia Day 1

    Post-operative day 1

  • Patient Use of Supplemental Narcotic Analgesia Day 2

    Post-operative day 2

  • Patient Use of Supplemental Narcotic Analgesia Day 3

    Post-operative day 3

  • Patient Use of Supplemental Narcotic Analgesia Day 4

    Post-operative day 4

  • Patient Use of Supplemental Narcotic Analgesia Day 0

    Post-operative day 0

Study Arms (2)

Continuous Preperitoneal Analgesia (CPA)

ACTIVE COMPARATOR

Continuous Preperitoneal Analgesia for pain management

Device: Continuous Preperitoneal Analgesia

Continuous Epidural Analgesia (CEA)

ACTIVE COMPARATOR

Continuous Epidural Analgesia for pain management

Device: Continuous Epidural Analgesia

Interventions

Preperitoneal catheter placed at the completion of surgery in the standard fashion.

Also known as: On-Q Silver Soaker(tm)
Continuous Preperitoneal Analgesia (CPA)

Epidural catheter placed prior to the operation in the standard fashion.

Continuous Epidural Analgesia (CEA)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> = 18 years
  • Scheduled for elective colon or rectal surgery
  • Surgical procedure either through open laparotomy or via minimal invasive approach (laparoscopic)
  • Able to provide informed consent
  • Able to complete patient questionnaire

You may not qualify if:

  • Documented allergic reaction to morphine, hydromorphone, lidocaine, bupivicaine and/or fentanyl
  • Contra-indication to placement of epidural catheter (spinal stenosis, spinal fusion, etc)
  • Urgent surgery precluding epidural catheter placement
  • Systemic Infection contraindicating epidural catheter placement
  • Unwillingness to participate in follow up assessments
  • Prisoners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saint Joseph Mercy Hospital

Ann Arbor, Michigan, 48106, United States

Location

Related Links

MeSH Terms

Conditions

Colonic NeoplasmsRectal NeoplasmsDiverticulosis, Colonic

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Results Point of Contact

Title
Dr. Robert Cleary
Organization
St. Joseph Mercy Hospital Ann Arbor

Study Officials

  • Robert Cleary, MD

    Trinity Health Michigan

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 28, 2012

First Posted

March 13, 2012

Study Start

January 1, 2010

Primary Completion

March 1, 2015

Study Completion

March 1, 2015

Last Updated

September 15, 2025

Results First Posted

September 15, 2025

Record last verified: 2025-08

Locations